Trial Details
Not recruitingBasic Information
| Clinical ID | c3013 |
|---|---|
| Identifier | NCT02437591 |
| Trial Title | Open Label Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD);Clostridium Difficile Infection (CDI) |
| Interventions | Drug: fidaxomicin |
Participant Information
| Sponsor | Astellas Pharma Europe Ltd. |
|---|---|
| City | - |
| Country/Region | Austria;France;Greece;Italy;Poland;Russia;United Kingdom;Czech Republic;Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |